Health Care: Drugs

Nivalis Therapeutics Inc (NVLS: NASDAQ)

$14.42 n/a | n/a%
09/01/15 - 03:59 PM ET
Latest Dividend:
Latest Dividend Yield:%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
NVLSSector Avg.S&P 500
n/a024.87
Price Performance History (% change):
3 Mo1 Yr3 Yr
GROWTH12 Mo3 YrCAGR
Revenue00
Net Income00
EPS0n/a
Earnings for NVLS:
EBITDA-14.00
REVENUE0.00
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $-0.37 $-0.31 $-1.41 $-1.97
Number of Analysts 3 3 3 3
High Estimate $-0.22 $-0.22 $-1.40 $-0.85
Low Estimate $-0.53 $-0.42 $-1.43 $-2.92
Prior Year $n.a. $n.a. $n.a. $-1.41
Growth Rate (Year over Year) n.a.% n.a.% n.a.% -39.15%

Portfolios with NVLS

Latest NVLS Headlines from TheStreet

More Financial News for NVLS

Press Releases for NVLS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter